(Q28206491)

1

0 references

E Penny

2

0 references

A A Silver

3

0 references

J Goldman

4

0 references

P R Sanberg

Journal of Human Hypertension

5

0 references

language of work or name

English

0 references

publication date

July 2002

0 references

published in

0 references

volume

16

0 references

issue

7

0 references

page(s)

453-7

0 references

cites work

Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

What is the nature of mecamylamine's antagonism of the central effects of nicotine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Mecamylamine: new therapeutic uses and toxicity/risk profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Nicotine‐sensitive paresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Nicotine induced seizures blocked by mecamylamine and its stereoisomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Nicotinic acetylcholine receptors as targets for antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Smoking cessation in women. Special considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Bupropion for smoking cessation : predictors of successful outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Smoking and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

How smoking affects blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Nicotine-mecamylamine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

The effects of alcoholism and smoking on platelet eicosanoid production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

Interaction of tobacco-specific toxicants with nicotinic cholinergic regulation of fetal pulmonary neuroendocrine cells: implications for pediatric lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

Oral nicotine induces an atherogenic lipoprotein profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021

Nicotine administration induced changes in the gonadal functions in male rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001416

7 January 2021